Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=250"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=250

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00449670-deaths",
        "title": "H5N1 Adjuvanted Group vs H5N1 Un-adjuvanted Group: deaths from any cause",
        "summary": "1 of 961 against 0 of 245; risk difference 0.1 points, 95% interval -1.4 to 0.6; NCT00449670, Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults",
        "record": "/library/comparisons/NCT00449670-deaths",
        "nct_id": "NCT00449670",
        "kind": "deaths",
        "participants": 1206,
        "risk_difference": {
          "value": 0.001040582726326743,
          "lower": -0.014420554442176596,
          "upper": 0.005870607850164397
        },
        "group_1": "1 of 961",
        "group_2": "0 of 245",
        "difference": "0.1 points",
        "interval": "-1.4 to 0.6",
        "trial_title": "Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults"
      },
      {
        "id": "NCT00449670-sae",
        "title": "H5N1 Adjuvanted Group vs H5N1 Un-adjuvanted Group: serious adverse events",
        "summary": "25 of 961 against 5 of 245; risk difference 0.6 points, 95% interval -2.2 to 2.2; NCT00449670, Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults",
        "record": "/library/comparisons/NCT00449670-sae",
        "nct_id": "NCT00449670",
        "kind": "serious-adverse-events",
        "participants": 1206,
        "risk_difference": {
          "value": 0.005606404892862453,
          "lower": -0.02214179846030292,
          "upper": 0.02241526310445212
        },
        "group_1": "25 of 961",
        "group_2": "5 of 245",
        "difference": "0.6 points",
        "interval": "-2.2 to 2.2",
        "trial_title": "Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=251",
  "request_id": "poyHlZTaWi9nthWW"
}